D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction

European Heart Journal

Volumn 20, Issue 20, 1999, Pages 1493-1502

  Tataru, M C ^a   Heinrich, J ^b   Junker, R ^c   Schulte, H ^c   Von Eckardstein, A ^c   Assmann, G ^c   Koehler, E ^d  

^a Department of Cardiology   (Germany)

^b Bethanien Hospital Solingen   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

^d Hospital Meiningen   (Germany)

Author keywords

Age dependency; D dimer; Fibrinolysis; Left ventricular dysfunction; Myocardial infarction

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; LIPID; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ANGINA PECTORIS; ANGIOLOGY; ARTERIOSCLEROSIS; ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; CARDIOLOGY; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEVICE; DISEASE SEVERITY; FEMALE; FIBRIN METABOLISM; FIBRINOLYSIS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN TISSUE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PLASMA VISCOSITY; PRIORITY JOURNAL; SEX DIFFERENCE; THROMBUS;

ADULT; ANGINA PECTORIS; AORTA, ABDOMINAL; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; BLOOD VISCOSITY; C-REACTIVE PROTEIN; CAROTID ARTERIES; CEREBRAL ARTERIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRINOLYSIS; HUMANS; MALE; MYOCARDIAL INFARCTION; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; ULTRASONOGRAPHY, DOPPLER, DUPLEX; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VENTRICULAR FUNCTION, LEFT;

EID: 0032837258     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1999.1519     Document Type: Article

References (49)

1. Lassila R, Peltonen S, Lepantalo M, Saarinen O, Kauhanen P, Manninen V. Severity of peripheral atherosclerosis is associated with fibrinogen and degradation of cross-linked fibrin. Arterioscler Thromb. 13:1993;1738-1742.
2. Lee AJ, Fowkes FGR, Lowe GDO, Rumley A. Fibrin D-dimer, haemostatic factors and peripheral arterial disease. Thromb Haemost. 74:1995;828-832.
3. Bolibar I, Kienast J, Thompson SG, Matthias R, Niessner H, Fechtrup C. Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. Am Heart J. 125:1993;1601-1605.
4. Eur Heart J. 14:1993;8-17.
5. Eichner JE, Moore WE, McKee PA. Fibrinogen levels in women having coronary angiography. Am J Cardiol. 78:1996;15-18.
6. Hamsten A, Wiman B, De Faire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med. 313:1985;1557-1563.
7. Hamsten A, de Faire U, Walldius G. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987.
8. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 341:1993;1165-1168.
9. Becker DM, Philbrick JT, Bachhuber TL, Humphries JE. D-dimer testing and acute venous thromboembolism. A shortcut to accurate diagnosis. Arch Intern Med. 156:1996;939-946.
10. Beek van EJ, Schenk BE, Michel BC. The role of plasma D-dimers concentration in the exclusion of pulmonary embolism. Br J Haematol. 92:1996;725-732.
11. Boisclair MD, Lane DA, Wilde JT, Ireland H, Preston FE, Ofosu FA. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen. Br J Haematol. 74:1990;471-479.
12. Brenner B, Francis CW, Fitzpatrick PG. Relation of plasma D-dimer concentrations coronary artery reperfusion before and after thrombolytic treatment in patients with acute myocardial infarction. Am J Cardiol. 63:1989;1179-1184.
13. Brenner B, Francis CW, Totterman S. Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation. Circulation. 81:1990;1818-1825.
14. Giansante C, Fiotti N, Cattin L, Da-Col PG, Calabrese S. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors. Thromb Haemost. 71:1994;581-586.
15. Gurfinkel E, Bozovich G, Cerda M, Mejail I, Oxilia A, Mautner B. Time significance of acute thrombotic reactant markers in patients with and without silent myocardial ischemia and overt unstable angina pectoris. Am J Cardiol. 76:1995;121-124.
16. Gurfinkel E, Altman R, Scazziota A, Rouvier J, Mautner B. Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina. Br Heart J. 71:1994;151-155.
17. Koh SC, Chew CY, Viegas OA, Choo M, Ratnam SS. Influence of circulating D-dimer levels on assays of fibrinogen. Ann Acad Med Singapore. 23:1994;856-860.
18. Koppensteiner R, Speiser W, Minar E, Ahmadi R, Ehringer H. D-dimer in local thrombolytic therapy with low doses of recombinant human tissue-type plasminogen activator (rt-PA) in patients with peripheral arterial occlusive disease. Thromb Haemost. 64:1990;192-195.
19. Kornberg A, Francis CW, Marder VJ. Plasma crosslinked fibrin polymers: quantitation based on tissue plasminogen activator conversion to D-dimer and measurement in normal and patients with acute thrombotic disorders. Blood. 80:1992;709-717.
20. Lawler CM, Bovill EG, Stump DC, Collen DJ, Mann KG, Tracy RP. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction. Blood. 76:1990;1341-1348.
21. Raimondi P, Bongard O, de Moerloose P, Reber G, Waldvogel F, Bounameaux H. D-dimer plasma concentration in various clinical conditions: implication for the use of this test in the diagnostic approach of venous thromboembolism. Thromb Res. 69:1993;125-130.
22. Salvioni A, Marenzi GC, Agostoni P, Grazi S, Guazzi MD. Influence of heparin on fibrinogen and D-dimer plasma levels in acute myocardial infarction treated with streptokinase. Eur Heart J. 15:1994;654-659.
23. Tengborn L, Palmblad S, Wojciechowski J, Peterson LE, Stigendal L. D-dimer and thrombin/antithrombin III complex-diagnostic tools in deep venous thrombosis? Haemostasis. 24:1994;344-350.
24. Wells PS, Brill-Edwards P, Stevens P. A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. Circulation. 91:1995;2184-2187.
25. Widder B. Doppler- und Duplex-Sonographie der hirnversorgenden Arterien. 1991;Springer-Verlag.
26. Kriessmann A, Bollinger A, Keller HM. Praxis der Doppler-Sonographie. 1990;Thieme, Stuttgart, New York.
27. Lüning M, Felix R. Komplexe bildgebende Diagnostik Abdomen. 1989;Thieme, Leipzig.
28. Kaltenbach M. Vom Belastungs-EKG zur Koronarangiographie. 1980;Springer, Berlin, Heidelberg, New York.
29. Schamroth L. EKG bei koronarer Herzkrankheit. 1988;Thieme, Stuttgart.
30. Lichtlen PR. Koronarangiographie. 1990;Perimed, Erlangen.
31. Schoop W. Praktische Angiologie. 1988;Thieme-Verlag, Stuttgart-New York.
32. Heinrich J, Schulte H, Schoenfeld R, Koehler E, Assmann G. Association of variables of coagulation, fibrinolysis and acute-phase with atherosclerosis in coronary and peripheral arteries and those arteries supplying the brain. Thromb Haemost. 73:1995;374-379.
33. Nie, NH, Hull, CH, Jenkins, JG, Statistical Package for the Social Sciences (SPSS), New York, McGraw-Hill.
34. Smith E. Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Clin Haematol. 15:1986;355-370.
35. Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med. 317:1987;1361-1365.
36. Francis CW, Connaghan DG, Scott WL, Marder V. Increased plasma concentration of cross-linked fibrin polymers in acute myocardial infarction. Circulation. 75:1987;1170-1177.
37. Tanaka M, Suzuki A. Hemostatic abnormalities in acute myocardial infarction as detected by specific blood markers. Thromb Res. 76:1994;289-298.
38. Salvioni A, Perego GB, Marenzi G, Lauri G, Giraldi F, Grazi S, Guazzi MD. Late activation of the fibrinolytic system in myocardial infarction treated with thrombolytic therapy. Eur Heart J. 17:1996;230-236.
39. Curries MS, Rao MK, Blazer DG, Cophen HJ. Age and functional correlations of markers of coagulation and inflammation in the elderly: functional implications of elevated crosslinked fibrin degradation products (D-dimers). J Am Geriatr Soc. 42:1994;738-742.
40. Kario K, Matsuo T, Kobayashi H. Which factors affect high D-dimer levels in the elderly? Thromb Res. 62:1991;501-508.
41. Lee AJ, Fowkes GR, Lowe GD, Rumley A. Determinations of fibrin D-dimer in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol. 15:1995;1094-1097.
42. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Circulation. 91:1995;284-290.
43. Al-Zahrani H, Lowe GDO, Douglas JT, Cushieri R, Pollock JG, Smith WCS. Increased fibrin turnover in peripheral arterial disease: comparison with a population study. Clin Hemorheol. 12:1992;876-872.
44. De Buyzere M, Philippe J, Duprez D, Baele G, Clement DL. Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease. Am J Hematol. 43:1993;91-94.
45. Fowkes FGR, Lowe GDO, Housley E. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet. 342:1993;84-86.
46. Smith FB, Lowe GDO, Fowkes FGR. Smoking, haemostatic factors and lipid peroxides in a population case control study of peripheral arterial disease. Atherosclerosis. 102:1993;155-162.
47. Lip GY, Lowe GD, Metcalfe MJ, Rumley A, Dunn FG. Is diastolic dysfunction associated with thrombogenesis? A study of circulating markers of a prothrombotic state in patients with coronary artery disease. Int J Cardiol. 50:1995;31-42.
48. Lip GYH, Lowe GDO, Metcalfe MJ, Rumley A, Dunn FG. Effects of warfarin therapy on plasma fibrinogen, von Willebrand factor, and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysms. Am J Cardiol. 76:1995;453-458.
49. Yasaka M, Miyatake K, Mitani M. Intracardiac mobile thrombus and D-dimer fragment of fibrin in patients with mitral stenosis. Br Heart J. 66:1991;22-25.